lamivudine has been researched along with HTLV-I Infections in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Balestrieri, E; Macchi, B; Mastino, A | 1 |
| Chizzolini, C; Landis, T; Perren, F; Pot, C; Ribi, C; Tiercy, JM; Vokatch, N | 1 |
| Machuca, A; Soriano, V | 1 |
1 review(s) available for lamivudine and HTLV-I Infections
| Article | Year |
|---|---|
Effects of nucleoside-based antiretroviral chemotherapy on human T cell leukaemia/lymphotropic virus type 1 (HTLV-1) infection in vitro.
Topics: Animals; Anti-Retroviral Agents; HTLV-I Infections; Human T-lymphotropic virus 1; Humans; Lamivudine; Nucleosides; Zidovudine | 2003 |
2 other study(ies) available for lamivudine and HTLV-I Infections
| Article | Year |
|---|---|
Combined antiviral-immunosuppressive treatment in human T-lymphotrophic virus 1-Sjögren-associated myelopathy.
Topics: Adenine; Antiviral Agents; Drug Therapy, Combination; Female; HTLV-I Infections; Humans; Immunosuppressive Agents; Lamivudine; Magnetic Resonance Imaging; Methylprednisolone; Middle Aged; Organophosphonates; Prednisone; Radiography; Sjogren's Syndrome; Tenofovir | 2006 |
In vivo fluctuation of HTLV-I and HTLV-II proviral load in patients receiving antiretroviral drugs.
Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; Drug Therapy, Combination; Female; HIV-1; HTLV-I Infections; HTLV-II Infections; Human T-lymphotropic virus 1; Human T-lymphotropic virus 2; Humans; Lamivudine; Middle Aged; Proviruses; T-Lymphocytes; Viral Load; Zidovudine | 2000 |